Cohesin, a ring-shaped SMC complex, mediates sister-chromatid cohesion, DNA repair, and genome folding via loop extrusion. Pluripotent and somatic cells were thought to rely solely on mitotic cohesin (SMC1A, SMC3, RAD21, STAG1/STAG2), while meiosis-specific subunits (SMC1B, REC8, STAG3) were considered germline-restricted. This notion has been challenged, as transcriptomic, proteomic, and chromatin-based evidence shows REC8 and STAG3 are expressed in embryonic stem cells (ESCs), assemble with core subunits like SMC3, and occupy genomic sites distinct from canonical RAD21-cohesin. Here, we compare meiotic and mitotic cohesin in subunit composition, expression, regulatory sensitivities, residence times, and removal mechanisms. We examine how each complex regulates enhancer-promoter communication, couples to the rapid pluripotent cell cycle, and how ESC gene-regulatory landscapes differ from differentiated fibroblasts. We extend the principle that cohesin is recruited by active cis -regulatory elements and lineage-determining transcription factors to build cell-type-specific chromatin domains, applying this to meiotic cohesin variants in pluripotent nuclei. Finally, we discuss how REC8/STAG3-containing complexes support replication-fork protection and genome stability during the shortened ESC cell cycle. These findings show that the meiotic-mitotic chromosome organization boundary is permeable, with meiotic cohesin acting as a noncanonical regulator of chromatin architecture and gene expression in pluripotent stem cells.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: